Addex Therapeutics Ltd. (ADXN) Earnings Signals & AI Vibe Check

Latest Filing: 20-F  |  Filed May 15, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Addex Therapeutics Ltd.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 20-F, Addex Therapeutics Ltd.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Turned Negative
GEMINI
Continuing Negative
CLAUDE
Continuing Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Addex Therapeutics Ltd. actually do?
Answer:
Addex Therapeutics Ltd. is a clinical-stage biopharmaceutical company focused on developing orally available small molecule allosteric modulators for neurological disorders. The company's pipeline includes drug candidates for post-stroke/traumatic brain injury recovery, substance use disorders, and chronic cough. Its lead compound, dipraglurant, is an mGlu5 negative allosteric modulator being evaluated for brain injury recovery. Addex Therapeutics also holds a 20% equity interest in Neurosterix US Holdings LLC, a private company developing drug candidates for schizophrenia and mood disorders. The company's strategy involves out-licensing programs and seeking collaborations to advance its pipeline, having raised significant equity financing to fund its operations.
Question:
What are Addex Therapeutics Ltd.'s revenue drivers?
Answer:
Revenue is primarily generated from license fees, milestone payments, and research and development activities related to its collaborative agreements with partners like Indivior and formerly Janssen.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required